Neurogenic Voiding Disorders
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB13694 | Distigmine | A cholinesterase inhibitor indicated in the treatment of neurogenic bladder dysfunction or myasthenia gravis. |
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|